FilingFirehose · free AI preview
Quoin Pharmaceuticals, Ltd.
QNRX · AI-generated SEC analysis preview · refreshes when data changes
Quoin Pharmaceuticals (QNRX) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, but absence of recent events does not equal absence of risk. The full $49 Report expands the analysis window to 12 months, quantifies dilution risk from past financing rounds, maps the complete 8-K history including equity raises, and surfaces AI-detected risk signals in SEC filings. Our report adds the dilution score, financing trajectory context, and forward-looking red flags that a 90-day snapshot cannot capture.
Want the full 5-section $49 Report on QNRX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.